权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Vitamin K, Bone, and Arterial Calcification

维生素 K、骨骼和动脉钙化

基本信息

批准号：
7092645
负责人：
REIDAR WALLIN
金额：
$ 31.53万
依托单位：
WAKE FOREST UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
起止时间：
2003-07-01 至 2008-12-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): Bone specific proteins, including vitamin K-dependent proteins, are found in calcified tissues outside the skeleton suggesting that the mechanism of ectopic calcification is similar to osteogenesis in the skeleton. Differentiation of cells into bone forming cells (osteoblasts) is central to the calcification process. Therefore, an understanding of the factors involved in osteoblast differentiation and how this process is regulated is essential for therapeutic interventions designed to prevent pathological calcification of the arterial system. The main focus of this grant is to understand the involvement of the vitamin K-dependent protein, Matrix Gla protein (MGP), in bone formation. Recent experiments have demonstrated that MGP is an important calcification inhibitor of the arterial system and cartilage. Importantly, its regulatory role in the calcification process has been shown to be dependent upon the vitamin K modification of the protein, which links its function to vitamin K metabolism, function and vitamin K nutrition. We have been able to show that MGP is a binding protein for bone morphogenetic protein-2 (BMP-2), a growth factor that will transform mesenchymal cells and subpopulations of vascular smooth muscle cells in the arterial wall into bone forming cells. We propose that MGP regulates the growth factor activity of BMP-2. We demonstrate that the Gla region on MGP is a binding site for BMP-2 and hypothesize that the vitamin K modification of MGP is essential for neutralizing the growth factor activity of BMP-2. We propose experiments to test this hypothesis in cell culture and in a rat model where arterial calcification can be induced by the vitamin K antagonist warfarin. Binding interactions between MGP and BMP-2 will be studied with Surface Plasmon Resonance (SPR). MGP is an insoluble 14 kDa matrix protein. We show that an intracellular form of MGP appears as a soluble 50 kDa protein and we propose experiments to reveal how this precursor is processed into its 14 kDa insoluble form. 35S-Met labeling of cell protein combined with a proteomic MS/MS approach will be used. We propose that oxidative stress damages the vitamin K-dependent gamma-carboxylation system in atherosclerotic plaques and the aging vessel wall resulting in inadequate gamma-carboxylation of MGP and onset of pathological calcification. This hypothesis will be tested in a rabbit atherosclerosis model and in aging rats. The proposed work will provide basic knowledge of BMP-2 growth factor mediated calcification as it is linked to the function of a fat-soluble vitamin (vitamin K) and biosynthesis of vitamin K-dependent proteins.

描述(申请人提供)：骨骼特定的蛋白质，包括维生素K依赖的蛋白质，在骨骼外的钙化组织中被发现，这表明异位钙化的机制类似于骨骼中的成骨。细胞分化为骨形成细胞(成骨细胞)是钙化过程的中心。因此，了解成骨细胞分化过程中涉及的因素以及这一过程是如何调节的，对于旨在预防动脉系统病理性钙化的治疗干预至关重要。这项资助的主要重点是了解维生素K依赖蛋白--基质GLA蛋白(MGP)--在骨形成中的作用。最近的实验证明，MGP是一种重要的动脉系统和软骨钙化抑制因子。重要的是，它在钙化过程中的调节作用已被证明依赖于蛋白质的维生素K修饰，该修饰将其功能与维生素K代谢、功能和维生素K营养联系起来。我们已经证明MGP是骨形态发生蛋白-2(BMP-2)的结合蛋白，BMP-2是一种生长因子，可以将动脉壁中的间充质细胞和血管平滑肌细胞亚群转化为骨形成细胞。我们认为MGP对BMP-2的生长因子活性有调节作用。我们证明了MGP上的GLA区域是BMP-2的结合部位，并假设MGP的维生素K修饰对于中和BMP-2的生长因子活性是必不可少的。我们建议在细胞培养和大鼠模型中进行实验来验证这一假设，在大鼠模型中，维生素K拮抗剂华法林可以诱导动脉钙化。MGP与BMP-2的结合作用将用表面等离子激元共振(SPR)研究。MGP是一种不溶于水的14 kDa基质蛋白。我们证明了MGP的一种细胞内形式以可溶的50 kDa蛋白质的形式出现，我们建议通过实验来揭示这种前体是如何被加工成其14 kDa的不可溶形式的。将结合蛋白质组MS/MS方法对细胞蛋白进行35S-Met标记。我们认为，氧化应激损伤动脉粥样硬化斑块和老化血管壁中依赖维生素K的伽玛-羧化系统，导致MGP的伽马-羧化不足，并开始病理性钙化。这一假说将在兔动脉粥样硬化模型和衰老大鼠身上进行验证。这项拟议的工作将提供BMP-2生长因子介导的钙化的基本知识，因为它与脂溶维生素(维生素K)的功能和维生素K依赖蛋白质的生物合成有关。